Linda M Ercoli

Author PubWeight™ 30.69‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 PET of brain amyloid and tau in mild cognitive impairment. N Engl J Med 2006 6.02
2 Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. Am J Geriatr Psychiatry 2002 2.80
3 Effects of a 14-day healthy longevity lifestyle program on cognition and brain function. Am J Geriatr Psychiatry 2006 1.93
4 Brain network local interconnectivity loss in aging APOE-4 allele carriers. Proc Natl Acad Sci U S A 2011 1.60
5 Plaque and tangle imaging and cognition in normal aging and Alzheimer's disease. Neurobiol Aging 2008 1.49
6 Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia. Arch Gen Psychiatry 2009 1.44
7 PET scanning of brain tau in retired national football league players: preliminary findings. Am J Geriatr Psychiatry 2013 1.27
8 Complementary use of tai chi chih augments escitalopram treatment of geriatric depression: a randomized controlled trial. Am J Geriatr Psychiatry 2011 1.20
9 Family history of Alzheimer's disease and hippocampal structure in healthy people. Am J Psychiatry 2010 1.05
10 Estrogen use and brain metabolic change in postmenopausal women. Neurobiol Aging 2005 1.04
11 Longitudinal changes in medial temporal cortical thickness in normal subjects with the APOE-4 polymorphism. Neuroimage 2010 1.00
12 Depression and anxiety symptoms are associated with cerebral FDDNP-PET binding in middle-aged and older nondemented adults. Am J Geriatr Psychiatry 2009 0.97
13 Prediction of cognitive decline by positron emission tomography of brain amyloid and tau. Arch Neurol 2012 0.94
14 The memory fitness program: cognitive effects of a healthy aging intervention. Am J Geriatr Psychiatry 2012 0.93
15 Hippocampal atrophy in persons with age-associated memory impairment: volumetry within a common space. Psychosom Med 2002 0.92
16 Reduced hippocampal CA2, CA3, and dentate gyrus activity in asymptomatic people at genetic risk for Alzheimer's disease. Neuroimage 2009 0.90
17 Self-reported memory impairment and brain PET of amyloid and tau in middle-aged and older adults without dementia. Int Psychogeriatr 2012 0.84
18 APOE associated hemispheric asymmetry of entorhinal cortical thickness in aging and Alzheimer's disease. Psychiatry Res 2013 0.83
19 Healthy behavior and memory self-reports in young, middle-aged, and older adults. Int Psychogeriatr 2013 0.83
20 Cognitive and cerebral metabolic effects of celecoxib versus placebo in people with age-related memory loss: randomized controlled study. Am J Geriatr Psychiatry 2008 0.82
21 Influence of Alzheimer disease family history and genetic risk on cognitive performance in healthy middle-aged and older people. Am J Geriatr Psychiatry 2012 0.81
22 Quantitative electroencephalography biomarkers of cognitive complaints after adjuvant therapy in breast cancer survivors: a pilot study. Psychooncology 2014 0.79
23 Vascular risk and FDDNP-PET influence cognitive performance. J Alzheimers Dis 2013 0.77
24 Increasing depressive symptoms in children of Alzheimer parents. J Geriatr Psychiatry Neurol 2011 0.75